COFCO Biotechnology Balance Sheet Health
Financial Health criteria checks 5/6
COFCO Biotechnology has a total shareholder equity of CN¥10.8B and total debt of CN¥5.0B, which brings its debt-to-equity ratio to 45.8%. Its total assets and total liabilities are CN¥18.1B and CN¥7.2B respectively.
Key information
45.8%
Debt to equity ratio
CN¥4.95b
Debt
Interest coverage ratio | n/a |
Cash | CN¥1.27b |
Equity | CN¥10.82b |
Total liabilities | CN¥7.24b |
Total assets | CN¥18.05b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 000930's short term assets (CN¥7.6B) exceed its short term liabilities (CN¥6.7B).
Long Term Liabilities: 000930's short term assets (CN¥7.6B) exceed its long term liabilities (CN¥510.4M).
Debt to Equity History and Analysis
Debt Level: 000930's net debt to equity ratio (34.1%) is considered satisfactory.
Reducing Debt: 000930's debt to equity ratio has reduced from 57.6% to 45.8% over the past 5 years.
Debt Coverage: 000930's debt is well covered by operating cash flow (65.1%).
Interest Coverage: Insufficient data to determine if 000930's interest payments on its debt are well covered by EBIT.